Monitor for any dissident activity or material changes before the meeting. Given the micro-cap status, any significant insider or activist filing closer to the meeting date would be more impactful. The meeting itself is unlikely to produce share price movement.
Price Chart
Executive Summary
Decoy Therapeutics filed a DEFA14A notice of internet availability of proxy materials for its 2026 Annual Meeting (July 14, 2026). The board recommends voting FOR the election of three director nominees, advisory say-on-pay, and ratification of Ernst & Young as auditor. This is a routine proxy solicitation notice with no material financial disclosures or activist involvement.
Key Financial Metrics
Key Facts
- Annual Meeting scheduled for July 14, 2026, to be held virtually.
- Director nominees: Patricia Gauthier, Jonathan Lieber, Frederick E. Pierce.
- Board recommends FOR all three proposals: director election, say-on-pay, and auditor ratification (Ernst & Young).
- Market cap of $3M and 0% analyst bullish consensus indicate a micro-cap company with limited institutional interest.
Financial Impact
No financial impact disclosed - routine proxy solicitation
Risk Factors
- Low institutional ownership and high sell-side pessimism may depress vote participation.
- No activist or dissident involvement currently, but cross-filing amplifier patterns suggest potential for escalation if a proxy contest emerges.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-332792 |
| Document: 0001193125-26-332792-index-headers.html | 0001193125-26-332792 |
| Document: 0001193125-26-332792-index.html | 0001193125-26-332792 |
| Document: 0001193125-26-332792.txt | 0001193125-26-332792 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | EFFECT | $1.17 $0.9100 | ▼ −22.22% | ▼ −22.08% | $1.03 (−11.97%) |
Oct 7, 2026 20d ago | S-1 | $1.52 $1.23 | ▲ +19.08% | ▲ +18.80% | $1.03 (+32.24%) |
Sep 23, 2026 4w ago | 8-K | $3.11 $1.86 | ▲ +40.35% | ▲ +39.94% | $1.03 (+66.88%) |
Aug 4, 2026 12w ago | DEFA14A | $4.19 $3.60 | ▼ −14.08% | ▼ −14.43% | $1.03 (−75.42%) |
Jul 20, 2026 14w ago | EFFECT | $5.31 $3.74 | ▼ −29.50% | ▼ −29.10% | $1.03 (−80.58%) |
Jun 29, 2026 17w ago | 8-K | $9.59 $7.25 | ▲ +24.40% | ▲ +25.79% | $1.03 (+89.26%) |
Jun 25, 2026 17w ago | EFFECT | $5.92 $7.62 | ▲ +28.76% | ▲ +27.20% | $1.03 (−82.60%) |
Jun 4, 2026 20w ago | DEFA14A | $6.71 $5.90 | ▼ −12.07% | ▼ −9.52% | $1.03 (−84.65%) |
Apr 30, 2026 25w ago | 10-K/A | $6.05 $6.01 | ▼ −0.66% | ▼ −2.39% | $1.03 (−82.98%) |
Apr 2, 2026 29w ago | 8-K | $5.80 $5.84 | ▲ +0.69% | ▼ −2.93% | $1.03 (−82.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers